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Abstract
Background: Radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF) can be curative. 
There are conflicting data on whether AF associated atrial and ventricular structural remodeling re-
verses after ablation. The aim of this study was to evaluate the hemodynamic effect of AF ablation in 
patients with preserved left ventricular ejection fraction (LVEF). 
Methods: Forty three AF patients were studied (aged 56 ± 11 years; 29 male, 23% persistent AF, 
LVEF ≥ 50%) in whom RFCA was performed. Echocardiographic evaluation of atrial and ventricular 
diameters, volumes and strain imaging by two-dimensional speckle tracking were performed before and 
at least 6 months after RFCA. Nine patients had AF during baseline examination. 
Results: A significant decrease in the left (LA) and right (RA) atrial volume and an increase in the 
LA strain were observed 15 ± 7 months after RFCA. In the subgroup with baseline sinus rhythm, the 
increment in LA strain was only borderline significant. An increase in RA, right ventricular (RV) and 
Biatrial strain was noticed (p < 0.05). LVEF and global longitudinal strain of the left ventricle (LV), 
however, did not improve substantially. 
Conclusions: Radiofrequency catheter ablation of AF in patients with preserved LV systolic function 
results in significant improvement in RA and RV function with a substantial reduction in LA and 
RA size. No deleterious impact of AF ablation on LA function was revealed. (Cardiol J XXXX; XX, X: 
xx–xx)
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Introduction 
Radiofrequency catheter ablation (RFCA) has 
become a common treatment for atrial fibrillation 
(AF). RFCA improves symptoms and quality of 
life by reducing arrhythmia burden [1, 2]. Nev-
ertheless, AF ablation outcome regarding cardiac 
remodeling is still questionable. Imaging analysis 
such as echocardiography reveals that RFCA 
changes AF- induced remodeling which affects both 
the atrium and ventricle. It is known that RFCA 
improves ejection fraction (EF) in patients with 
heart failure and significantly decreases left atrial 
(LA) size, especially after successful restoration of 
sinus rhythm (SR) [3, 4]. However, despite both 
functional and structural changes after RFCA hav-
ing been widely studied the impact of AF ablation 
on myocardial muscle has not yet been determined. 
First, in patients with preserved left ventricular 
(LV) function from previous studies demonstrated 
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no change in EF [5, 6]. However, left ventricular 
ejection fraction (LVEF) estimation does not reflect 
subtle changes in LV and therefore the effect of AF 
ablation on LV function is still uncertain. Second, 
it is not known whether AF ablation results in 
any change in the right ventricular (RV) size and 
function. Finally, the effect of RFCA on both LA 
and right atrial (RA) functional changes remains 
uncertain. Therefore, it is controversial to what 
extent RFCA can stop AF induced cardiac remod-
eling. Recently two-dimensional speckle tracking 
echocardiography (2D-STE) has been widely ac-
cepted as an innovative method to evaluate the 
function and remodeling of the heart muscle. In 
addition, 2D-STE correlates with cardiac magnetic 
resonance imaging results [7, 8].
The aim of this mono-center prospective 
study was to evaluate the effect of AF ablation on 
hemodynamic using 2D-STE.
Methods
Patient enrollment 
Patients with paroxysmal or persistent non-
valvular AF who underwent RFCA during the 
period between January 2014 and December 2017 
were considered for enrollment. The exclusion cri-
teria were as follows: LVEF < 50% before RFCA, 
clinically significant valve disease or prosthetic 
valve, unstable coronary artery disease, bundle 
branch block, severe LV hypertrophy, uncontrolled 
thyroid or pulmonary disease in anamnesis. Finally, 
data for 43 consecutive patients were used for 
analyses in this study. The study was approved by 
local ethics committee (ethical approval reference 
number: NKBBN/505/2017) and all patients gave 
their written informed consent before procedures.
Electrophysiologic study  
and catheter ablation
One RFCA session was performed in 40 pa-
tients, and 3 patients needed a second session due 
to AF recurrences. The procedure was performed 
under conscious sedation using midazolam and 
fentanyl. A diagnostic catheter was positioned via 
the left femoral vein into the coronary sinus and 
the region of His bundle. Then via the right femoral 
vein a double transseptal puncture was performed 
and an ablation catheter (ThemoCool, SmartTouch, 
Biosense-Webster, CA, USA) and a multipolar 
catheter (Lasso, Biosense-Webster, CA, USA) were 
introduced into the LA. A three-dimensional elec-
troanatomical map was created using the Carto-3 
system (Biosense-Webster, CA, USA). All patients 
underwent extensive encircling pulmonary vein 
isolation (PVI) using a maximum power of 20–30 
Watts. During procedure the activated clotting 
time was controlled and maintained above 300 s. 
Bi-directional electrical PVI was considered the 
endpoint of ablation and was confirmed by the 
complete disappearance of pulmonary vein po-
tentials recorded by circular catheter and absence 
of veno-atrial conduction during intra-pulmonary 
vein pacing. A cavo-tricuspid isthmus block line 
was created in 1 (2%) patient who had documented 
atrial flutter, apart from AF.
Echocardiographic study
Transthoracic echocardiography was performed 
before and at least 6 months after RFCA using a 
Vivid E9 (General Electric Medical Health). Two-
dimensional (2D) and Doppler measurements were 
obtained according to recommendations for cardiac 
chamber quantification [9]. Cine loops from three 
standard apical views (4-, 3-, and 2-chamber) were 
recorded for off-line analysis (EchoPac 201, GE). 
Left atrial minimal and maximal volumes were 
calculated using the Simpson rule from 4- and 
2-chamber views. RA minimal and maximal vol-
umes were calculated using a single-plane method 
of disks from 4-chamber view. LA emptying fraction 
(LAEF) was calculated according to the formula: 
(maximum – minimum LA volume)/maximum LA 
volume × 100. Both, LA and RA volumes were 
indexed to body surface area (LAVI and RAVI).
Two-dimensional speckle tracking  
echocardiography
Left ventricular global longitudinal peak strain 
(LV-GLS) was calculated according to the recom-
mendations for cardiac chamber quantification [9]. 
Measurements were made in three standard apical 
views and expressed as a mean value.
Furthermore LA, RA and RV strain measure-
ments were performed according to the consensus 
document standardizing deformation imaging [10]. 
The measurements for LA were obtained at each 
myocardial segment of the apical 4-chamber view 
and for RA and RV of the RV-focused 4-chamber 
view. The endocardial wall borders were traced 
manually and a region of interest was created 
automatically by the software (EchoPac). Seg-
ments with inadequate tracking were excluded 
from analysis. The QRS wave was used as the 
zero point in both SR and AF rhythm. The average 
value from all 6 segments of LA or RA during the 
entire cardiac cycle was used for the final value 
of LA or RA positive peak strain. Additionally, 
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the endocardial border of LA and RA free wall 
was traced to obtain biatrial positive peak strain 
(excluding atrial septum). Similarly, as with atrial 
analysis, RV negative peak strain was calculated. 
The region of interest included both the RV free 
wall and interventricular septum. 
Follow-up
All patients were monitored by 12-lead electro-
cardiography (ECG) and 24-h Holter recording in an 
outpatient Arrhythmia Clinic at averagely 3, 6 and 12 
months after ablation. Anti-arrhythmic therapy was 
prescribed in patients with easily inducible AF. In 
cases of symptoms suggestive of AF immediate ECG 
or Holter recording was performed. Echocardio - 
graphy was repeated at least 6 months after RFCA. 
The ablation was considered successful if during 
the follow-up there was no recurrence of symptoms 
suggestive of AF, no AF recorded on standard ECG 
and no AF lasting > 30 s on Holter monitoring, after 
a blanking period of 3 months.
Statistical analysis
Statistical analysis was performed using the 
licensed Statistica 13 software (Statsoft Poland). 
Continuous variables are presented as mean ± 
standard deviations (SD) or median with first and 
third interquartile range. Statistical significance 
was defined as p < 0.05. The Shapiro-Wilk test was 
used to estimate the distribution. The c2 test with 
Yates correction was used for nonparametric data 
and the two-sample t-test for continuous variables. 
Comparison of the echocardiographic parameters 
before and after RFCA was performed by the paired 
sample t-test or Wilcoxon signed-rank test where 
appropriate. Two-way ANOVA with replication 
was used for comparison of the echocardiographic 
parameters before and after RFCA in the SR and 
AF group. Intra- and interobserver variability for 
strain measures were determined in 10 randomly 
selected patients and the variability was calculated 
as an absolute difference (in %) divided by the mean 
of the repeated measures.
Results
Baseline characteristics and follow-up
Baseline clinical characteristics of the patients 
enrolled (n = 43) is listed in Table 1. All analyzed 
patients had a history of AF of at least 1-year in 
Table 1. Clinical characteristics of the whole examined group and with division according to heart 
rhythm during the echocardiographic examination before arrhythmia ablation. 
Total  
(n = 43)
SR group  
(n = 34)
Group with  
baseline AF (n = 9)
*P value between  
SR and AF group
Age 56 ± 11 54 ± 12 60 ± 9 0.16
Sex (male) 29 (85%) 22 (65%) 7 (78%) 0.73
Hypertension 22 (51%) 17 (50%) 5 (56%) 0.94
Hypercholesterolemia 14 (33%) 10 (29%) 4 (45%) 0.65
Type 2 diabetes non-insulin dependent 2 (5%) 1 (4%) 1 (12%) 0.85
Stable CAD 2 (5%) 2 (6%) None 0.88
Obesity 2 (5%) 2 (6%) None 0.88
Persistent AF 10 (23%) 5 (15%) 5 (56%) < 0.05
Redo-PVI 3 (7%) 3 (9%) None 0.85
CTI ablation 1 (2%) 1 (4%) None 0.47
Amiodarone 6 (14%) 5 (15%) 1 (12%) 0.79
Sotalol 9 (21%) 7 (21%) 2 (23%) 0.72
I C anti-arrhythmic drugs 13 (30%) 11 (32%) 2 (23%) 0.86
No anti-arrhythmic drugs 17 (40%) 11 (32%) 6 (67%)  0.14
Beta-blocker (another than sotalol) 16 (37%) 13 (38%) 3 (33%) 0.91
ACEI/AT II 10 (23%) 8 (24%) 2 (22%) 0.72
Statin 17 (40%) 14 (41%) 3 (33%) 0.96
AF recurrence 11 (26%) 10 (29%) 1 (12%) 0.49
Age values are mean ± standard deviation. *Chi-squared test with Yates correction. SR — sinus rhythm; AF — atrial fibrillation; CAD — coronary 
artery disease; PVI — pulmonary vein isolation; CTI — cavo-tricuspid isthmus; ACEI — angiotensin-converting enzyme inhibitor;  
AT II — angiotensin II receptor blocker
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duration or longer (mean 4 ± 3 years). During 
the echocardiographic examination before RFCA 
34 (79%) patients were in SR (SR group), while 
9 (21%) had AF (AF group). A total of 28 (65%) 
patients took antiarrhythmic drugs before AF ab-
lation, 26 (60%) continued taking them after the 
procedure (7 of them discontinued between 2 and 
6 months). All patients had adequately controlled 
hypertension (blood pressure < 140/90 mmHg). 
The average number of antihypertensive drugs per 
patient was 1.1. There were no substantial differ-
ences in clinical characteristics such as age, sex, 
comorbidities, or pharmacotherapy before RFCA 
between the two groups. Only persistent AF was 
more frequent in the group with baseline AF. 
Successful PVI was completed in all patients; 
3 (7%) needed a second session; a cavo-tricuspid 
isthmus block line was created in 1 (2%) patient 
with documented atrial flutter. During a 15 ± 7 
month follow up, AF recurred in 11 (26%) patients, 
10 of them had SR during baseline echo examina-
tion.
Echocardiographic findings
Echocardiographic results are summarized in 
Tables 2 and 3. 
Table 2. Echocardiographic parameters in the whole group examined (n = 43) before and after  
radiofrequency catheter ablation (RFCA).
Baseline After RFCA P
Heart rate 57 ± 16 67 ± 10 0.51
Interventricular septum [mm] 10 (9–12) 11 (9–11) 0.55*
Posterior wall [mm] 9 ± 2 9 ± 1 0.63
LV end-diastolic diameter [mm] 50 ± 5 49 ± 5 0.49
LV end-systolic diameter [mm] 32 ± 5 32 ± 5 0.38
LV end-diastolic volume [mL] 88 (80–108) 91 (82–103) 0.44*
LV end-systolic volume [mL] 37 (30–45) 35 (30–44) 0.69*
LVEF [%] 60 ± 7 62 ± 6 0.15
LV-GLS [%] –18 ± 4 –19 ± 3 0.05
RV end-diastolic area [cm2] 18 (17–22) 18 (15–21) < 0.01*
TAPSE [mm] 22 ± 5 24 ± 3 0.01
s’ RV [m/s] 0.12 (0.12–0.15) 0.14 (0.13–0.15) 0.10*
RV strain [%] –19 (–16; –23) –23 (–20; –26) < 0.05*
LA diameter [mm] 39 ± 4 39 ± 4 0.31
LA min. volume [mL] 47 ± 21 38 ± 16 < 0.01
LA max. volume [mL] 83 ± 23 73 ± 20 < 0.01
LAVI [mL/m2] 41 ± 12 37 ± 11 0.01
LAEF [%] 44 ± 14 49 ± 11 0.07
LA strain [%] 23 ± 8 27 ± 7 < 0.001
RA min. volume [mL] 34 ± 18 26 ± 12 < 0.0001
RA max. volume [mL] 56 (48–68) 49 (41–60) 0.001*
RAVI [mL/m²] 27 (24–32) 24 (19–31) < 0.001*
RA strain [%] 27 ± 11 35 ± 10 < 0.001
Biatrial strain [%] 19 ± 9 26 ± 8 < 0.0001
E [m/s] 0.7 ± 0.2 0.7 ± 0.2 0.84
A [m/s] 0.6 ± 0.2 0.6 ± 0.1 0.21
e’ mean [cm/s] 1 ± 0.4 1 ± 0.3 0.16
E/e’ 7 (6–9) 7 (6–10) 0.43*
Values are mean ± standard deviation or median (first-third interquartile range) when normal distribution was not achieved. P value: t-test for 
related samples and where appropriate *Wilcoxon signed-rank test.
LV — left ventricle; LVEF — LV ejection fraction; LV-GLS — LV global longitudinal peak strain; RV — right ventricle; TAPSE— tricuspid annular 
plane systolic excursion by M-mode; s’ RV — peak systolic velocity of tricuspid annulus by spectral tissue Doppler; LA — left atrium; min. —  
minimum; max. — maximum; LA — left atrial; LAVI — LA volume index; LAEF — LA emptying fraction; RA — right atrium; RAVI — RA volume 
index; E — early transmitral flow velocity by pulsed wave Doppler; A — late transmitral flow velocity by pulsed wave Doppler; e’ — early  
diastolic mitral annulus velocity by spectral tissue Doppler
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Before RFCA mean LVEF, LV-GLS, LV size 
and LV wall thickness were within normal range 
in the present population. LV diastolic function 
was normal in 35 (81%) patients, whereas 8 (9%) 
patients revealed intermediate diastolic dysfunc-
tion [11]. The mean RV size and function were 
normal, however mean RV strain was slightly de-
teriorated [12]. Mean LAVI was enlarged and LA 
function expressed by LA strain was also impaired 
[13], especially in the AF group but also in the 
SR group. Mean RAVI was enlarged and baseline 
RA strain was impaired compared with healthy 
population [14].
Heart rate during the baseline and follow-up 
transthoracic examination (after 15 ± 7 months) 
was comparable. At follow-up a significant decrease 
in LA maximal, minimal and indexed volume was 
observed, however, LAVI did not normalize (did 
not achieve the value ≤ 34 mL/m2). Although a 
substantial 4 ± 7% improvement in LA strain was 
reported in the overall population, patients with 
baseline SR increment was only borderline sig-
nificant. Regarding RA and RV size: RA minimal, 
maximal and indexed volume, as well as RV end-
diastolic area decreased significantly.
Moreover, RA and biatrial strain showed 
significant improvement and increased: 8 ± 12% 
(p < 0.001), 7 ± 10%, (p < 0.0001), respectively 
(Fig. 1). The RV function improved regarding RV 
strain (decreased 3 ± 5%, p < 0.001) and tricus-
pid annular plane systolic excursion by M-mode 
(TAPSE) (p = 0.01).
There were no substantial differences be-
tween baseline and control parameters in LAEF, 
LV dimensions or volumes, LV diastolic function 
parameters including mitral E and A velocities, e’, 
E/e’. LVEF and LV-GLS were within normal range 
and showed no significant change (Table 2).
Differences between groups  
with baseline SR and AF
Patients with baseline AF presented a more 
pronounced reduction in minimal LA volume and 
improvement in LA strain, LAEF and biatrial 
Table 3. Comparison of the subgroup with sinus rhythm (SR group) and atrial fibrillation (AF group) 
during the echocardiographic examination before radiofrequency catheter ablation (RFCA) — selected 
parameters.
Variable SR group  
(n = 34)
AF group  
(n = 9)
^P value  
(SR group vs.  
AF group)
#P value  
(baseline vs.  
after RFCA)
Baseline After  
RFCA
Baseline After  
RFCA
SR  
group
AF  
group
Heart rate 62 ± 10 68 ± 10 87 ± 18 65 ± 10 < 0.0001 < 0.01 < 0.01
LVEF [%] 61 ± 6 61 ± 7 55 ± 11 63 ± 3 < 0.01 0.91 0.06
LV-GLS [%] –19 ± 3 –19 ± 4 –14 ± 4 –20 ± 2 < 0.0001 0.91 < 0.01
TAPSE [mm] 23 ± 4 24 ± 3 16 ± 2 23 ± 3 < 0.0001 0.60 < 0.0001
RV strain [%] –21 ± 5 –23 ± 5 –15 ± 3 –22 ± 2 < 0.01 < 0.01 < 0.0001
LA min. volume [mL] 43 ± 17 38 ± 17 65 ± 24 40 ± 15 < 0.01 0.12 < 0.01
LA max. volume [mL] 82 ± 22 72 ± 20 87 ± 29 79 ± 19 0.75 < 0.01 0.31
LAVI [mL/m2] 40 ± 11 37 ± 11 43 ± 12 40 ± 9 0.91 < 0.05 0.27
LAEF [%] 48 ± 11 48 ± 11 25 ± 10 51 ± 9 < 0.0001 0.96 0.001
LA strain [%] 25 ± 6 27 ± 8 14 ± 5 25 ± 7 < 0.001 0.05 < 0.0001
RA min. volume [mL] 27 (23–33) 24 (16–28) 45 (34–50) 33 (24–34) < 0.05 < 0.001 0.01*
RA max. volume [mL] 53 (48–60) 49 (41–59) 73 (59–80) 59 (41–68) 0.29 < 0.01* 0.01
RAVI [mL/m2] 26 (24–30) 24 (19–29) 36 (30–40) 31 (21–34) 0.48 < 0.001* < 0.05
RA strain [%] 30 ± 10 36 ± 10 17 ± 6 31 ± 10 0.07 0.01 < 0.01
Biatrial strain [%] 22 ± 9 26 ± 8 10 ± 4 24 ± 8 < 0.01 < 0.01 0.0001
E [m/s] 0.7 ± 0.2 0.7 ± 0.2 0.9 ± 0.2 0.7 ± 0.2 < 0.05 0.41 0.05
e’ mean [cm/s] 1 ± 0.3 1 ± 0.3 1.3 ± 0.2 0.9 ± 0.2 < 0.001 0.79 < 0.001
E/e’ 8 ± 3 8 ± 3 7 ± 2 7 ± 4 0.81 0.32 0.54
Values are mean ± standard deviation or median (first-third interquartile range) when normal distribution was not achieved. ^Two-way ANOVA 
with replication; #P value: t-test for related samples and where appropriate; *Wilcoxon signed-rank test; abbreviations — see Table 2
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strain at the follow-up examination than SR group 
(Fig. 2A–C). Larger improvement in RV function 
regarding RV strain and TAPSE in the AF group 
was also noticed (Fig. 2E). RA strain improved and 
RA volumes decreased to a similar degree in the 
SR and AF group (Fig. 2D). Additional substantial 
improvement in LVEF and GLS was noticed in the 
AF group (Fig. 2F, Table 3).
Reproducibility 
The reproducibility of the strain measurement 
was good. Intra- and interobserver variability was cal-
culated as the absolute difference (in %) divided by the 
mean of the repeated measures were 2.6% and 10.8% 
for LA strain, 0.3% and 0.2% for RA strain, 1.5% and 
4.1% for biatrial strain, 5.6% and 3.0% for RV strain 
and 3.6% and 2.1% for LV-GLS, respectively.
Figure 1. An example of a patient from the sinus rhythm (SR) group demonstrating improvements in right atrial 
(RA), biatrial strain and right ventricle (RV) strain after radiofrequency catheter ablation (RFCA). A. RA strain before: 
32%; B. RA strain after: 40%; C. Biatrial strain before: 20%; D. Biatrial strain after: 27%; E. RV strain before: –27%; 
F. RV strain after: –32%.
A
C
E
B
F
D
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Discussion
The present results show a significant im-
provement in RA and RV function with a substantial 
reduction in LA and RA size after RFCA of symp-
tomatic AF. According to available research, this is 
the first study to determine RA and RV function 
pre- and post-AF ablation using 2D-STE.
It is known that LA size, which is a surrogate 
measure of LA structural remodeling, decreases 
after AF ablation [4, 15, 16]. This is in agreement 
with the current study showing a significant re-
duction in the minimal, maximal and indexed LA 
volumes after PVI in the whole group examined. 
There are still discrepancies regarding avail-
able data concerning LA function recovery after AF 
Figure 2. Changes in atrial and ventricular function according to baseline heart rhythm; A. Left atrial (LA) strain, B. LA 
emptying fraction (LAEF); C. Biatrial strain; D. Right atrial (RA) strain; E. Right ventricular (RV) strain; F. Left ventricular 
global longitudinal peak strain (LV-GLS); (––) atrial fibrillation (AF) group; (––) sinus rhythm (SR) group; SR vs. AF 
group — two-way ANOVA with replication; vertical bars represent 0.95 confidence intervals; baseline vs. follow-up 
in the AF and SR group separately — T-test for related samples *p < 0.01; **p < 0.001.
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ablation [15, 17–19]. This inconsistency is probably 
the result of a variety of LA function parameters used 
in different studies, divergent timelines, diverse im-
aging techniques and finally LA measurements ana-
lyzed during AF or SR. Among the many parameters 
in use to assess LA performance the present study 
focused on LA longitudinal peak positive strain. The 
LA is a reservoir, a conduit and a pump, and plays an 
important role in modulating LV filling [10]. In order 
not to exclude patients with AF, QRS was chosen as 
the reference point. In this setting LA peak positive 
strain corresponds to LA reservoir function while in 
previous studies it was correlated with structural LA 
remodeling/fibrosis [7, 20].
The results of the present study indicate 
significant increases in LA strain in the overall 
population with no substantial change in the SR 
group (Fig. 2A). The improvement in LA function 
only in the whole group was probably the result of 
AF occurrence during baseline echocardiography 
in 9 patients. If baseline imaging is acquired during 
AF and the control in SR, variation of the LA strain 
may be overestimated. 
Tops et al. [21] demonstrated significant im-
provement in LA strain after PVI. Contrary to the 
present study, the strain value was obtained by 
color-coded tissue Doppler imaging in patients with 
a relatively small baseline LAVI compared with 
population herein (30 ± 7 vs. 41 ± 12 mL/m2). Ad-
ditionally, it is unknown how many patients had AF 
during echocardiographic examination before PVI. 
In agreement the present SR group results, 
another study [22] also showed no significant 
change in LA strain pre- and post-PVI in patients 
with paroxysmal and persistent AF. However, the 
authors did not provide information about patient 
heart rhythm during image acquisition. 
Finally, regarding LAEF, no substantial change 
was seen in the overall population or in the SR 
group (baseline LAEF was > 40% in both groups). 
This is in agreement with Antolini et al. [19] who 
reported that only patients with baseline LAEF < 
40% had significant improvement in LA perfor-
mance after ablation. 
Santoro et al. [23] showed that uncontrolled 
hypertension confers higher AF recurrence risk 
after RFCA and can affect outcome regarding LA 
diameter and scar extension. Patients from the 
current study, however, had well controlled blood 
pressure with drugs, so it was believed that the 
influence of hypertension on LA strain values was 
minimal [23].
In sum, PVI exerts a beneficial effect on LA 
hemodynamics. However, despite LA volume de-
cline, only minor improvement in LA function was 
observed. These discrepancies can be explained 
by the fact that changes in LA function after AF 
ablation depend on the balance between the ben-
eficial effect of atrial reverse remodeling after SR 
restoration and the harmful effect of fibrosis and 
edema caused by the ablation procedure. 
In agreement with a previous series the pre-
sent study shows a significant reduction in RA size 
after PVI [24, 25], which is probably a result of SR 
restoration. It was also shown that changes in LA 
and RA volume were significantly correlated and 
reverse remodeling was faster in the RA than in 
the LA [24, 26]. It is known, that cavo-tricuspid 
isthmus ablation in RA may lead, per se, to volume 
reduction via the scaring process. Regarding the 
current study however, only 1 patient underwent 
such ablation.
According to available research, an improve-
ment in the RA function in terms of RA strain is 
presently reported for the first time. In contrast 
to LA strain, RA strain improved both in the SR 
and AF group, however to a higher degree in the 
AF group. This observation is in agreement with 
Wylie et al. [25], who reported a significant increase 
in RAEF after AF ablation. However, the analysis 
was based on 33 patients who underwent PVI of 
which 20 also had a cavo-tricuspid isthmus block 
line created due to atrial flutter. According to all 
available research, the impact of RFCA on RV func-
tion remains unknown. The present data showed 
significant improvement in RV function (expressed 
by an increase in TAPSE and RV strain) with con-
comitant RV end diastolic area reduction. Probably, 
an improvement in RA function ultimately results 
in favorable RV reverse remodeling and vice versa. 
There are a lack of studies to compare these results 
to and thus, it is believed that this will encourage 
further investigation. 
No significant improvement in LVEF was ob-
served in the current analysis in patients with LVEF 
≥ 50%. LV-GLS revealed borderline improvement 
in the overall population (p = 0.05) with significant 
improvement in the AF group and no change in the 
SR group. LV-GLS is a very sensitive parameter 
and in spite of almost normal LVEF in the AF 
group (≥ 50%) during baseline echocardiographic 
examination, LV-GLS was already substantially 
impaired. Previous studies have demonstrated a 
beneficial effect of AF ablation on LV function in 
patients with heart failure and impaired LVEF [3, 
4]. Nevertheless, in patients with preserved LVEF 
the effect of RFCA on LV function was considered 
less favorable as EF remained unchanged after 
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ablation [5]. Subtle changes in LV however, may 
not be detected using conventional methods. Indeed, 
preliminary data in patients with preserved LVEF 
show that LV deformation may improve after AF abla-
tion. Previous studies revealed a significant increase 
in the absolute values of circumferential and LV-GLS, 
particularly in patients who maintained SR after PVI 
[6, 27]. Furthermore Lin et al. [28] described subtle 
LV changes using another echocardiographic method 
— vector flow mapping, evaluating LV energy loss. 
This parameter, as a marker of structural LV remod-
eling, almost normalized at 6 months follow-up after 
successful RFCA. Similarly, substantial improvement 
of native T1 mapping assessed by cardiac magnetic 
resonance — a marker of reverse LV remodeling 
— was observed only in patients with successfully 
restored SR following RFCA [29]. All of the above-
mentioned studies, found significant LV improvement 
in patients with preserved LVEF only after success-
ful RFCA. After ablation, SR maintained 74% in the 
present study population.
According to available research, this is the first 
study that assesses changes in biatrial strain before 
and after PVI (Fig. 1C, D). In this study biatrial 
strain showed significant improvement regardless 
of the rhythm during baseline examination. A con-
sidered opinion herein posits that the evaluation 
of atrial free wall strain can more precisely assess 
true atrial remodeling due to the avoidance of ar-
tifactual dropout of the atrial septum. In addition, 
this parameter can be a common thread regarding 
atrial assessment as changes in LA and RA volume 
are significantly correlated [23].
Difference between the SR group  
and group with baseline AF
The baseline AF group showed more pro-
nounced improvement in cardiac function and 
greater LA minimal and RA volume decrease 
than SR group. This may be explained by several 
hypotheses. First, persistent AF was significantly 
more frequent in the AF group, and PVI is probably 
more effective regarding reverse remodeling in 
patients with persistent AF. Second, a significant 
increase in heart rate was found in the SR and a 
decrease in the AF group between the baseline and 
control echocardiographic examination (Table 3). 
Therefore, improvement in cardiac function after 
RFCA in the AF group could be more related to 
normalization of heart rate than to maintenance of 
SR. Finally, measurements in the AF group were 
collected during AF before RFCA and SR at follow-
up. Thus, variations of functional and volumetric 
parameters could have been overestimated. 
Limitations of the study
First, the low sample size and relatively short 
follow up are limitations of the current analysis. 
Second, although 2D-STE software is primarily 
designed for LV analysis, it was used for atrial and 
RV deformation measurements, having said that 
however, reproducibility of the measurements is 
good. Third, the differences between patients with 
AF recurrences (11 patients) and patients with 
maintenance of SR after RFCA were not analyzed. 
Finally, some patients had a discordant rhythm 
during baseline and follow-up image acquisition 
and this could have influenced comparisons of 
echocardiographic parameters. 
Conclusions
The present study used 2D-STE showing 
that AF ablation induces favorable structural and 
functional remodeling mainly within the RA and 
RV. PVI reduces LA volume without a deleterious 
impact on its function. The improvement is higher 
in patients with AF during baseline examination. 
Present observations may further encourage phy-
sicians to consider ablation in relatively young, 
healthy patients with AF and without obvious 
structural heart disease in order to reverse the 
AF induced incipient cardiomyopathy and restore 
normal cardiac function.
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